Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Pamela Stephenson currently holds 25,500 shares of Zynerba Pharmaceuticals, Inc. (ZYNE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Pamela Stephenson has been a net seller of ZYNE stock. They have purchased $0 and sold $286.5K worth of shares.
Pamela Stephenson's most recent insider trade was on Feb 10, 2026, when they sold 25,500 shares at $0.00 per share.
Pamela Stephenson serves as Executive at Zynerba Pharmaceuticals, Inc. (ZYNE). They have executed 37 insider transactions totaling $286.5K over their tenure at the company.
Pamela Stephenson holds the position of Executive at Zynerba Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Pamela Stephenson has shown a selling trading pattern, with $0 in total purchases and $286.5K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Pamela Stephenson was on Jan 19, 2023, when they sold $77.9K worth of ALBO shares. This transaction involved 1,774 shares at $43.90 per share.
Pamela Stephenson currently owns 25,500 shares of Zynerba Pharmaceuticals, Inc. (ZYNE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Pamela Stephenson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Pamela Stephenson has 37 Form 4 filings on record as an insider at Zynerba Pharmaceuticals, Inc..
Set alerts for Pamela Stephenson and 40,000+ other insiders.